TrialBlood advances2022

GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trial.

Vincent T Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.